[go: up one dir, main page]

BR9200786A - Utilizacao de agentes de penetracao hidrofilos e composicao dermatologica para o tratamento de onicomicoses - Google Patents

Utilizacao de agentes de penetracao hidrofilos e composicao dermatologica para o tratamento de onicomicoses

Info

Publication number
BR9200786A
BR9200786A BR929200786A BR9200786A BR9200786A BR 9200786 A BR9200786 A BR 9200786A BR 929200786 A BR929200786 A BR 929200786A BR 9200786 A BR9200786 A BR 9200786A BR 9200786 A BR9200786 A BR 9200786A
Authority
BR
Brazil
Prior art keywords
dermatological composition
agents
penetration
onicomycosis
hydrophyl
Prior art date
Application number
BR929200786A
Other languages
English (en)
Inventor
Jean Pierre Laugier
Marie-France Rude
Philippe Touzan
Francois Ringenbach
Original Assignee
Oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oreal filed Critical Oreal
Publication of BR9200786A publication Critical patent/BR9200786A/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q3/00Manicure or pedicure preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41Amines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Emergency Medicine (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Cosmetics (AREA)
BR929200786A 1991-03-08 1992-03-09 Utilizacao de agentes de penetracao hidrofilos e composicao dermatologica para o tratamento de onicomicoses BR9200786A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9102838A FR2673537B1 (fr) 1991-03-08 1991-03-08 Utilisation d'agents de penetration hydrophiles dans les compositions dermatologiques pour le traitement des onychomycoses, et compositions correspondantes.

Publications (1)

Publication Number Publication Date
BR9200786A true BR9200786A (pt) 1992-11-17

Family

ID=9410536

Family Applications (1)

Application Number Title Priority Date Filing Date
BR929200786A BR9200786A (pt) 1991-03-08 1992-03-09 Utilizacao de agentes de penetracao hidrofilos e composicao dermatologica para o tratamento de onicomicoses

Country Status (17)

Country Link
US (3) US5814305A (pt)
EP (1) EP0503988B1 (pt)
JP (1) JP3559973B2 (pt)
AT (1) ATE190485T1 (pt)
AU (1) AU1147092A (pt)
BR (1) BR9200786A (pt)
CA (1) CA2062341C (pt)
CY (1) CY2233B1 (pt)
DE (1) DE69230772T2 (pt)
DK (1) DK0503988T3 (pt)
ES (1) ES2144409T3 (pt)
FR (1) FR2673537B1 (pt)
GR (1) GR3033297T3 (pt)
MX (1) MX9200965A (pt)
PT (1) PT503988E (pt)
SG (1) SG46660A1 (pt)
ZA (1) ZA921706B (pt)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8697753B1 (en) 2013-02-07 2014-04-15 Polichem Sa Method of treating onychomycosis

Families Citing this family (85)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2673537B1 (fr) 1991-03-08 1993-06-11 Oreal Utilisation d'agents de penetration hydrophiles dans les compositions dermatologiques pour le traitement des onychomycoses, et compositions correspondantes.
US6005001A (en) * 1991-05-20 1999-12-21 Novartis Ag (Formerly Sandoz Ag) Pharmaceutical composition
HU223343B1 (hu) * 1991-05-20 2004-06-28 Novartis Ag. Allil-amin-származékot tartalmazó gyógyászati készítmények és eljárás azok előállítására
HU219480B (hu) * 1991-05-23 2001-04-28 Novartis Ag. Eljárás gombás körömmegbetegségek ellen helyileg alkalmazható, allil-amin-származékot tartalmazó gyógyászati készítmények előállítására
US5652256A (en) * 1995-06-06 1997-07-29 Knowles; W. Roy Topical composition for fungal treatment
WO1998016251A1 (de) * 1996-10-16 1998-04-23 Ipr-Institute For Pharmaceutical Research Ag Neue carrier-systeme
WO1999039680A1 (en) * 1998-02-09 1999-08-12 Macrochem Corporation Antifungal nail lacquer and method using same
US6231875B1 (en) * 1998-03-31 2001-05-15 Johnson & Johnson Consumer Companies, Inc. Acidified composition for topical treatment of nail and skin conditions
CA2343284C (en) 1998-09-10 2008-11-18 Ipr-Institute For Pharmaceutical Research Ag Topical application products
US6159977A (en) * 1998-11-16 2000-12-12 Astan, Inc. Therapeutic anti-fungal nail preparation
US6517863B1 (en) 1999-01-20 2003-02-11 Usbiomaterials Corporation Compositions and methods for treating nails and adjacent tissues
DE10011081A1 (de) * 2000-03-09 2001-09-13 Aventis Pharma Gmbh Antiinfektive Wirkstoffkombinationen und ihre Verwendung zur topischen Behandlung von Pilzerkrankungen der Fuß- und Fingernägel
US8257688B2 (en) * 2000-03-27 2012-09-04 Taro Pharmaceuticals Industries Controlled delivery system of antifungal and keratolytic agents for local treatment of fungal infections of the nail and surrounding tissues
US7074392B1 (en) * 2000-03-27 2006-07-11 Taro Pharmaceutical Industries Limited Controllled delivery system of antifungal and keratolytic agents for local treatment of fungal infections
GB0014448D0 (en) * 2000-06-13 2000-08-09 Novartis Ag Organic compounds
GB0019283D0 (en) * 2000-08-04 2000-09-27 Novartis Ag Organic compounds
WO2006057616A1 (en) * 2004-11-29 2006-06-01 Ambria Dermatology Ab A composition comprising at least 3 different diols
US6664292B2 (en) 2001-06-04 2003-12-16 Mark H. Bogart Methods for the treatment of nail fungus and other microbial and mycotic conditions and compositions useful therefor
US7244703B2 (en) 2001-06-22 2007-07-17 Bentley Pharmaceuticals, Inc. Pharmaceutical compositions and methods for peptide treatment
US6821508B2 (en) 2001-06-27 2004-11-23 Rutgers, The State University Composition and method for topical nail treatment
US20030049307A1 (en) * 2002-08-15 2003-03-13 Gyurik Robert J. Pharmaceutical composition
CA2495923A1 (en) * 2002-08-20 2004-03-04 Doren M. Pinnell Methods for treating fungal infections
AU2003270273B2 (en) * 2002-09-05 2009-03-19 Galderma S.A. Solution for ungual application
FR2844197B1 (fr) * 2002-09-05 2006-06-23 Galderma Res & Dev Solution pour application ungueale et peri-ungeale
US20040126343A1 (en) * 2002-12-26 2004-07-01 Garshowitz Solomon David Nail drug delivery
AU2004224326B2 (en) * 2003-03-21 2010-04-22 Nexmed Holdings, Inc. Antifungal nail coat and method of use
WO2004108114A2 (en) * 2003-03-31 2004-12-16 Dinesh Shantilal Patel Anti-fungal composition and a process for its manufacture
JP4784051B2 (ja) * 2003-07-03 2011-09-28 大正製薬株式会社 容器への吸着を防止した外用抗真菌組成物
WO2005002561A1 (ja) * 2003-07-03 2005-01-13 Taisho Pharmaceutical Co.,Ltd. 外用抗真菌剤組成物
AU2004266053B2 (en) * 2003-08-25 2011-06-09 Bioequal Ag Pharmaceutical and cosmetic formulations for treating fingernails
DE10341944A1 (de) * 2003-09-11 2005-04-28 York Pharma Plc Antimykotisch wirksame Nagellackformulierung mit substituierten 2-Aminothiazolen als Wirkstoff
ATE474591T1 (de) 2003-12-08 2010-08-15 Cpex Pharmaceuticals Inc Pharmazeutische zusammensetzungen und verfahren für die insulinbehandlung
US20050238672A1 (en) * 2004-04-27 2005-10-27 Nimni Marcel E Antifungal drug delivery
US7740875B2 (en) * 2004-10-08 2010-06-22 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
US20060078580A1 (en) 2004-10-08 2006-04-13 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
US20060078599A1 (en) * 2004-10-12 2006-04-13 Mathew Ebmeier Pharmaceutical composition applicable to body tissue
AU2005314426A1 (en) * 2004-12-10 2006-06-15 Talima Therapeutics, Inc. Compositions and methods for treating conditions of the nail unit
US20060275230A1 (en) * 2004-12-10 2006-12-07 Frank Kochinke Compositions and methods for treating conditions of the nail unit
US20060165747A1 (en) * 2005-01-24 2006-07-27 David Rolf Antifungal composition, method and kit for topically treating onychomycosis
WO2006103638A2 (en) * 2005-03-31 2006-10-05 Ranbaxy Laboratories Limited Topical pharmaceutical compositions of terbinafine and processes for their preparation
CN103357015A (zh) * 2005-09-29 2013-10-23 瑞士商拜欧伊果公司 疣、指甲疾病、及指甲保养用之局部配方
MXPA05012961A (es) * 2005-11-30 2007-05-30 Fernando Ahumada Ayala Preparaciones para el cuidado de las unas que contienen clorhidrato de terbinafina.
KR20080080355A (ko) * 2005-12-28 2008-09-03 데이코쿠 세이야쿠 가부시키가이샤 손·발톱용 의약 조성물
AU2006332425A1 (en) * 2006-01-02 2007-07-12 Tlt Medical Ltd. Pharmaceutical composition for the treatment of nail diseases
US20090215888A1 (en) * 2006-03-02 2009-08-27 Singh Jagat Topical nail formulation
AU2006339842B2 (en) * 2006-03-08 2012-06-07 Nihon Nohyaku Co., Ltd. Pharmaceutical composition for external use
US8771726B2 (en) 2006-08-28 2014-07-08 Hisamitsu Pharmaceutical Co., Inc Nail patch
US20080135643A1 (en) * 2006-12-08 2008-06-12 Kimberly-Clark Worldwide, Inc. Pulsating spray dispensers
CN101652124A (zh) * 2007-02-05 2010-02-17 亲生物有限公司 烯丙胺药物化合物的增加的效力
WO2008121709A1 (en) * 2007-03-30 2008-10-09 Transport Pharmaceuticals, Inc. Pharmaceutical formulations for iontophoretic delivery of an anti-fungal drug
BRPI0810091A2 (pt) 2007-04-20 2014-10-21 Bioequal Ag Agentes fugicidas tópicos para tratar distúrbios ungueais
US20080287912A1 (en) * 2007-05-14 2008-11-20 Horrigan Corporation Method, Device And Formulation For The Treatment Of Nail Disorders
CN101808637B (zh) 2007-09-05 2013-07-24 宝丽制药股份有限公司 医药组合物
JP5453093B2 (ja) * 2007-09-05 2014-03-26 株式会社ポーラファルマ 抗真菌医薬組成物
US20100173965A1 (en) * 2007-09-05 2010-07-08 Pola Pharma Inc. Antifungal composition
WO2009048841A1 (en) * 2007-10-09 2009-04-16 Humco Holding Group, Inc. Antifungal treatment of nails
US8221370B2 (en) * 2007-10-31 2012-07-17 Kimberly-Clark Worldwide, Inc. Personal care article with substrate surface topography for evoking a neurosensory skin response
US7802314B2 (en) * 2007-10-31 2010-09-28 Kimberly-Clark Worldwide, Inc. Hand-wear article with cutaneous sensory elements
WO2009071959A2 (en) * 2007-12-04 2009-06-11 Pannonpharma Gyógyszergyártó Kft. A composition in the form of a paint tincture or lacquer to treat fungal infections containing itraconazole and a process for the preparation thereof
US20090175810A1 (en) 2008-01-03 2009-07-09 Gareth Winckle Compositions and methods for treating diseases of the nail
CN102395274B (zh) * 2009-02-13 2014-03-12 托派卡医药股份有限公司 抗真菌制剂
CA2784516C (en) 2009-02-26 2020-01-07 B.R.A.I.N. Biotechnology Research And Information Network Ag Compositions, use and method for the use of surface active proteins in topical drug delivery across keratin
FR2942716B1 (fr) * 2009-03-06 2011-04-15 Galderma Res & Dev Methode de solubilisation d'agent antifongique et compositions a haute concentration en agent antifongique applicables sur l'ongle
US20120309753A1 (en) * 2009-03-06 2012-12-06 Galderma Research & Development Method of dissolving antifungal agent, and compositions with a high concentration of antifungal agent, suitable for application to the nail
WO2010117089A2 (en) 2009-04-09 2010-10-14 Pola Pharma Inc. Antimycotic pharmaceutical composition
JP5688406B2 (ja) 2009-04-09 2015-03-25 株式会社ポーラファルマ 抗真菌医薬組成物
DE102009038512A1 (de) 2009-07-30 2011-02-10 Technische Universität Braunschweig Arzneimittelformulierung zur Behandlung von Nagelerkrankungen
WO2011014850A2 (en) * 2009-07-31 2011-02-03 Nuvo Research Inc. Topical eutectic-based formulations
US8952044B2 (en) 2009-08-25 2015-02-10 Pola Pharma Inc. Antimycotic pharmaceutical composition
NL2003786C2 (en) 2009-11-11 2010-07-30 Medner B V COMPOSITION FOR TOPICAL APPLICATION, USES THEREOF, APPLICATOR DEVICE AND KIT OF PARTS.
EP2544659A2 (en) 2009-12-23 2013-01-16 Nuvo Research Inc. Highly permeating terbinafine formulation for treating onychomycosis
US8039494B1 (en) 2010-07-08 2011-10-18 Dow Pharmaceutical Sciences, Inc. Compositions and methods for treating diseases of the nail
US20120061267A1 (en) * 2010-09-14 2012-03-15 Sally Villalobos MediTowel Anti-Fungal Wipe
EP2462991A1 (en) 2010-12-13 2012-06-13 PQS Group B.V. Composition and use of a fermented olive leaf product for the treatment of nail infections
WO2014159060A1 (en) 2013-03-14 2014-10-02 Hallux, Inc. Method of treating infections, diseases or disorders of nail unit
JP6516759B2 (ja) 2013-10-03 2019-05-22 ダウ ファーマシューティカル サイエンシーズ,インコーポレイティド 安定化エフィナコナゾール組成物
KR102612453B1 (ko) 2013-11-22 2023-12-08 다우 파마슈티컬 사이언시즈, 인코포레이티드 항­감염 방법,조성물,및 장치
WO2016015094A1 (en) * 2014-07-31 2016-02-04 Acrux Dds Pty Ltd Topical composition
WO2017031075A1 (en) * 2015-08-17 2017-02-23 Arno Therapeutics, Inc. Methods and compositions for enhanced transungual delivery of ar-12
JP6895429B2 (ja) * 2015-10-07 2021-06-30 エクソドス ライフ サイエンシーズ リミテッド パートナーシップ 局所抗真菌組成物
US10993890B2 (en) 2018-03-15 2021-05-04 Pelli Skin Co., Llc Antifungal solution and foot wipe
CN108653195A (zh) * 2018-08-08 2018-10-16 江苏知原药业有限公司 透皮或透粘膜给药制剂
JP2022518357A (ja) * 2018-12-19 2022-03-15 マーリンズ・ファーマ・エルエルシー 局所組成物
WO2020231800A1 (en) * 2019-05-10 2020-11-19 Encube Ethicals Private Limited Topical antifungal formulation
EP4129292A1 (en) 2021-08-04 2023-02-08 OnychoPharm GmbH Formulation for substituted 2-aminothiazoles in the treatment of fungal and fungal-bacterial infections of the nail

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4291015A (en) * 1979-08-14 1981-09-22 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing a vasodilator
EP0024587B1 (en) * 1979-08-22 1984-11-14 Sandoz Ag Propenylamines, processes for their production, pharmaceutical compositions containing them and their use as pharmaceuticals
FR2572933B1 (fr) * 1981-04-06 1988-03-18 Sandoz Sa Compositions pharmaceutiques topiques a base de tizanidine
FR2502951B1 (fr) * 1981-04-06 1985-12-06 Sandoz Sa Compositions pharmaceutiques topiques sous forme d'une micro-emulsion
JPS60224638A (ja) * 1984-04-23 1985-11-09 Kao Corp 経皮吸収促進剤およびこれを含有する外用剤
JPS6169721A (ja) * 1984-09-13 1986-04-10 Kao Corp 抗真菌組成物
AU599064B2 (en) * 1985-11-04 1990-07-12 Dermatological Products Of Texas Film-forming, pharmaceutical vehicles for application of medicaments to nails, pharmaceutical compositions based on those vehicles, and methods of using same
US5256647A (en) * 1986-01-31 1993-10-26 Whitby Research, Inc. Compositions comprising 1-substituted azacycloalkanes
JPS63502282A (ja) * 1986-01-31 1988-09-01 ホイットビ−・リサ−チ・インコ−ポレ−テッド 1−置換アザシクロアルカン類より成る組成物とその用法
US4946870A (en) * 1986-06-06 1990-08-07 Union Carbide Chemicals And Plastics Company Inc. Delivery systems for pharmaceutical or therapeutic actives
US4782059A (en) * 1986-09-29 1988-11-01 Merck & Co., Inc. Method of controlling mycotic infections and compositions therefor
FR2613227B1 (fr) * 1987-04-01 1990-12-28 Oreal Compositions pharmaceutiques a base de nitrate de miconazole ou de nitrate d'econazole dans le traitement des infections fongiques des ongles
DE3720147A1 (de) * 1987-06-16 1988-12-29 Hoechst Ag Antimykotisch wirksamer nagellack sowie verfahren zu dessen herstellung
US4920112A (en) * 1988-04-18 1990-04-24 Merck & Co., Inc. Fungicidal compositions and method
US5181914A (en) * 1988-08-22 1993-01-26 Zook Gerald P Medicating device for nails and adjacent tissue
US5116603A (en) * 1989-01-31 1992-05-26 Yissum Research Development Company Of The Hebrew University Of Jerusalem Oral antifungal preventative, and method of use
US5053227A (en) * 1989-03-22 1991-10-01 Cygnus Therapeutic Systems Skin permeation enhancer compositions, and methods and transdermal systems associated therewith
JP2797401B2 (ja) * 1989-04-19 1998-09-17 日産化学工業株式会社 爪用抗真菌剤組成物
FR2646603B1 (fr) * 1989-05-03 1991-07-12 Oreal Composition nettoyante
JPH0338522A (ja) * 1989-07-05 1991-02-19 Maruho Kk 抗真菌性組成物
JPH0338521A (ja) * 1989-07-05 1991-02-19 Maruho Kk 抗真菌性組成物
FR2673537B1 (fr) * 1991-03-08 1993-06-11 Oreal Utilisation d'agents de penetration hydrophiles dans les compositions dermatologiques pour le traitement des onychomycoses, et compositions correspondantes.
US5215520A (en) * 1991-09-17 1993-06-01 Centre Internationale De Recherches Dermatologiques Galderma (C.I.R.D. Galderma) Method for delivering an active substance topically or percutaneously
US5661170A (en) * 1994-03-21 1997-08-26 Woodward Laboratories, Inc. Antimicrobial compositions and methods for using the same

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8697753B1 (en) 2013-02-07 2014-04-15 Polichem Sa Method of treating onychomycosis
US9107877B2 (en) 2013-02-07 2015-08-18 Polichem Sa Method of treating onychomycosis
US10172811B2 (en) 2013-02-07 2019-01-08 Polichem Sa Topical antifungal composition for treating onychomycosis

Also Published As

Publication number Publication date
EP0503988A1 (fr) 1992-09-16
GR3033297T3 (en) 2000-09-29
CA2062341C (fr) 2004-05-11
CY2233B1 (en) 2003-04-18
US6143793A (en) 2000-11-07
DE69230772D1 (de) 2000-04-20
DK0503988T3 (da) 2000-07-24
DE69230772T2 (de) 2000-07-27
ES2144409T3 (es) 2000-06-16
PT503988E (pt) 2000-06-30
SG46660A1 (en) 1998-02-20
ZA921706B (en) 1992-11-25
MX9200965A (es) 1992-09-01
US6455592B1 (en) 2002-09-24
FR2673537A1 (fr) 1992-09-11
JP3559973B2 (ja) 2004-09-02
AU1147092A (en) 1992-09-10
FR2673537B1 (fr) 1993-06-11
ATE190485T1 (de) 2000-04-15
EP0503988B1 (fr) 2000-03-15
US5814305A (en) 1998-09-29
CA2062341A1 (fr) 1992-09-09
JPH0585929A (ja) 1993-04-06

Similar Documents

Publication Publication Date Title
BR9200786A (pt) Utilizacao de agentes de penetracao hidrofilos e composicao dermatologica para o tratamento de onicomicoses
FI872481A0 (fi) Kiinteä, hallitusti vapauttava lääkeaineen kantoaineena käytettävä matriisi
IE940583L (en) Topical antimicrobial pharmaceutical compositions
FI875272L (fi) Baerarloesningsmedelssystem i tvao fas.
EP0251464A3 (en) Composition for the control of insects
PT697814E (pt) Formulacoes para verter que contem material polimerico glicois e gliceridos
CA2241464A1 (en) Nisin in combination with glycerol monolaurate active against helicobacter
CA2284774A1 (en) Theobromine antitussive compositions
ES2058228T3 (es) Compuestos activos sobre el sistema cardiovascular.
ATE79256T1 (de) Zusammensetzung gegen coccidiosis.
EP0400219A3 (en) Use of creosote as an antispasmodic agent
SU1459215A1 (ru) Состав полимерной диффузионной матрицы для трансдермального введения лекарственных веществ
DE59101818D1 (de) Arzneimittelzubereitung, enthaltend Stigmasta-4-en-3-on sowie deren Verwendung.
CA2113080A1 (en) Topical composition containing penciclovir
EP0685230A4 (en) STABLE DERMATOLOGICAL PREPARATIONS CONTAINING MYCOHENOLIC ACID.
KR920702623A (ko) 진해제
IT8520514A0 (it) Composizioni di farmaci dotate di attivita' antimicrobica eprocedimento per la loro preparazione.
HUT46506A (en) Insecticidal and game repellent synergetic compositions
IT8919283A0 (it) Composizione farmaceutica comprendente come ingrediente attivo 3 n piperidinometil azino metilrifamicina s.

Legal Events

Date Code Title Description
FA1 Application withdrawn (art. 18(2))